EnerSys Inc. (ENS) Financials Nov 17, 2014, 4:23
EnerSys Inc. (ENS) Financials Nov 17, 2014, 4:23 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for EnerSys Inc.
Fiscal year is April-March. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 1.58B 1.96B 2.28B 2.28B 2.47B
Cost of Goods Sold (COGS) incl. D&A 1.23B 1.52B 1.77B 1.71B 1.84B
COGS excluding D&A 1.19B 1.48B 1.72B 1.66B 1.79B
Depreciation & Amortization Expense 44.85M 44.39M 50.36M 50.5M 53.97M
Depreciation 44.15M 43.52M 48.53M 47.88M 49.69M
Amortization of Intangibles 706,000 876,000 1.83M 2.63M 4.28M
Gross Income 348.5M 442.96M 517.42M 564.34M 629.61M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 235.6M 259.22M 297.81M 312.32M 344.42M
Research & Development - 0 0 0 0
Other SG&A 235.6M 259.22M 297.81M 312.32M 344.42M
Other Operating Expense 0 0 0 0 0
Unusual Expense 18.07M 6.62M 5.17M (344,000) 95.88M
EBIT after Unusual Expense (18.07M) (6.62M) (5.17M) 344,000 (95.88M)
Non Operating Income/Expense 8.02M (1.8M) (6.7M) (3.41M) (8.46M)
Non-Operating Interest Income 0 1.3M 0 1.4M 1M
Equity in Affiliates (Pretax) - 0 - - -
Interest Expense 15.6M 24.8M 16.48M 20.12M 18.11M
Gross Interest Expense 16.53M 26.09M 17.28M 20.12M 19.15M
Interest Capitalized 929,000 1.29M 797,000 - 1.05M
Pretax Income 87.26M 151.83M 191.26M 230.23M 163.75M
Income Tax 24.95M 38.02M 47.29M 65.28M 16.98M
Income Tax - Current Domestic 8.02M 26.97M 34.24M 44.16M 44.1M
Income Tax - Current Foreign 9.96M 14.11M 16.28M 19.44M 22.63M
Income Tax - Deferred Domestic 5.53M 652,000 (2.57M) 4.13M (22.5M)
Income Tax - Deferred Foreign 1.45M (3.72M) (656,000) (2.46M) (27.25M)
Income Tax Credits - 0 - - -
Equity in Affiliates - 0 - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 62.3M 113.81M 143.97M 164.96M 146.77M
Minority Interest Expense 0 382,000 (36,000) (1.55M) (3.56M)
Net Income 62.3M 113.43M 144M 166.51M 150.33M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 62.3M 113.43M 144M 166.51M 150.33M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 62.3M 113.43M 144M 166.51M 150.33M
EPS (Basic) 1.29 2.30 2.95 3.47 3.17
Basic Shares Outstanding 48.12M 49.38M 48.75M 48.02M 47.47M
EPS (Diluted) 1.28 2.27 2.93 3.42 3.02
Diluted Shares Outstanding 48.83M 50.04M 49.22M 48.64M 49.79M
EBITDA 157.76M 228.13M 269.97M 302.52M 339.16M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Top 5 Most Recently Viewed Articles
Investment Overview of Graphic Packaging Holding Graphic Packaging Holding Co (NYSE: GPK) has demonstrated impressive growth over the last two decades, surpassing market averages with an annualized return of 10.07%. The company's market capitalization currently stands at $5.95 billion, reflecting its significant presence in the packaging industry. Initial Investment Value...
Continue Reading
Haier and Roland-Garros: A Partnership Built on Excellence As the prestigious Roland-Garros tournament unfolds, the iconic clay courts come alive with energy, highlighting the shared values of excellence and innovation between Haier and this celebrated event. Introduced in 2023, this strategic partnership marks its third year, reinforcing both entities' commitment to...
Continue Reading
The Appeal of the Swiss Franc in Carry Trades Investors are increasingly turning to the Swiss franc as a viable alternative to Japan's yen for carry trades, but the currency's potential for swift rallies remains a key concern. The Swiss franc has long been a favorite in carry trading, a strategy where traders borrow currencies with lower interest rates and convert them...
Continue Reading
LGCY Power Strategically Partners with Builders to Expand LGCY Power, recognized as a top-ranked solar installation company in the U.S., is taking significant strides to grow its residential solar business. The company has recently forged partnerships with national homebuilders to provide innovative solar solutions for new home constructions. This strategic move reflects...
Continue Reading
Understanding the Trends in Lockheed Martin's Options Market Lockheed Martin (LMT) is drawing significant attention from investors, particularly with a bearish sentiment prevailing among large-scale traders. This observation encourages retail investors to pay close attention to the unfolding dynamics within the options market for this defense giant. Recent tracking of...
Continue Reading